https://www.selleckchem.com/pr....oducts/cilofexor-gs-
9 vs. 6.2 months, respectively; p=0.05. We demonstrated that ATM loss could be a prognostic marker after platinum-based chemotherapy in patients with advanced EH-CCC. We demonstrated that ATM loss could be a prognostic marker after platinum-based chemotherapy in patients with advanced EH-CCC. We established a data-driven method for extracting spatial patterns of dose distribution associated with radiation injuries, based on patients with prostate cancer who underwent iodine-125 (I-125) seed implantation. Seventy-five patient
Like
Comment
Share
